Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.10.0.1
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Basic and diluted numerator:        
Net loss attributable to iBio, Inc. stockholders $ (4,469) $ (3,899) $ (8,867) $ (7,725)
Preferred stock dividends 65 65 131 131
Net loss available to iBio, Inc. stockholders $ (4,534) $ (3,964) $ (8,998) $ (7,856)
Basic and diluted denominator:        
Weighted-average common shares outstanding 18,688 9,661 18,291 9,613
Per share amount $ (0.24) $ (0.41) $ (0.49) $ (0.82)